Earnings History Data for Aurinia Pharmaceuticals Inc (AUPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin for the treatment of lupus nephritis. Aurinia Pharmaceuticals Inc. is headquartered in Victoria, Canada.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	PM		AUPH	Aurinia Pharmaceuticals Inc	1,050	0.10	0.02	-0.09	Aurinia Pharma GAAP EPS of $0.10 beats by $0.09, revenue of $67.77M beats by $10.08M [11/7/2024 6:05 AM]	8.34	0.82 (10.91%)	7.80	0.28 (3.72%)	4.71 - 10.05	3,899,031	990,000	73,249
Aurinia Pharma Q3 2024 Earnings Preview [11/6/2024 3:28 PM] Aurinia Pharma GAAP EPS of $0.10 beats by $0.09, revenue of $67.77M beats by $10.08M [11/7/2024 6:05 AM] Aurinia stock jumps 14% on Q3 earnings, restructuring announcement [11/7/2024 2:24 PM] Aurinia Pharmaceuticals Reports Third Quarter and Nine Months 2024 Financial and Operational Results, Announces Strategic Restructuring to Sharpen Focus on Continued LUPKYNIS Growth and AUR200 Development [2024-11-07 06:00AM]
01-08-2024	PM		AUPH	Aurinia Pharmaceuticals Inc	803.77	0.02	0.01	-0.08	Aurinia Pharma beats Q2 estimates, narrows FY revenue guidance [8/1/2024 6:05 AM]	5.61	-0.27 (-4.68%)	5.76	-0.12 (-2.04%)	4.71 - 11.52	1,375,500	1,520,000	18,368
Aurinia Pharma Q2 2024 Earnings Preview [7/31/2024 12:14 PM] Aurinia Pharma beats Q2 estimates, narrows FY revenue guidance [8/1/2024 6:05 AM]
02-05-2024	PM		AUPH	Aurinia Pharmaceuticals Inc	724.53	-0.03	-0.17	-0.18	Aurinia Pharma GAAP EPS of -$0.07 beats by $0.07, revenue of $50.3M beats by $3.23M [5/2/2024 6:09 AM]	5.16	-0.04 (-0.87%)	5.54	0.34 (6.54%)	4.71 - 12.43	3,109,969	1,330,000	38,425
Aurinia Pharma GAAP EPS of -$0.07 beats by $0.07, revenue of $50.3M beats by $3.23M [5/2/2024 6:09 AM] Aurinia Pharma Q1 2024 Earnings Preview [5/1/2024 11:43 AM]
15-02-2024	PM		AUPH	Aurinia Pharmaceuticals Inc	1,120	-0.19	-0.18	-0.18	Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M [2/15/2024 6:02 AM]	6.01	-1.96 (-24.59%)	6.01	-1.96 (-24.59%)	5.50 - 12.43	17,337,193	1,800,000	1,877,720
Aurinia Pharma Q4 2023 Earnings Preview [2/14/2024 10:53 AM] Aurinia Pharma GAAP EPS of -$0.19 misses by $0.03, revenue of $45.1M misses by $0.06M [2/15/2024 6:02 AM] Aurinia drops after Q4 miss; strategic review fails [2/15/2024 7:05 AM]
02-11-2023	PM		AUPH	Aurinia Pharmaceuticals Inc	1,050	-0.09	-0.17	-0.06	Aurinia Pharma GAAP EPS of -$0.09 beats by $0.08, revenue of $54.52M beats by $16.02M [11/2/2023 6:02 AM]	7.88	0.75 (10.52%)	7.88	0.0 (0.00%)	4.07 - 12.43	3,083,202	1,410,000	42,124
Aurinia Pharma Q3 2023 Earnings Preview [11/1/2023 1:08 PM] Aurinia Pharma GAAP EPS of -$0.09 beats by $0.08, revenue of $54.52M beats by $16.02M [11/2/2023 6:02 AM] Aurinia Pharma spikes after Q3 beat; narrows guidance [11/2/2023 10:51 AM]
03-08-2023	PM		AUPH	Aurinia Pharmaceuticals Inc	1,490	-0.08	-0.20	-0.25	Aurinia Pharma GAAP EPS of -$0.08 beats by $0.11, revenue of $41.49M beats by $3.98M [8/3/2023 6:02 AM]	10.56	0.43 (4.24%)	10.25	0.12 (1.18%)	4.07 - 12.43	7,755,876	2,910,000	387,723
Aurinia Pharma Q2 2023 Earnings Preview [8/2/2023 1:39 PM] Aurinia Pharma GAAP EPS of -$0.08 beats by $0.11, revenue of $41.49M beats by $3.98M [8/3/2023 6:02 AM] Aurinia spikes on Q2 earnings beat, guidance raise [8/3/2023 6:40 AM]
04-05-2023	PM	6:00 AM ET (May 4)	AUPH	Aurinia Pharmaceuticals Inc	1,660	-0.18	-0.23	-0.27	Aurinia Pharma GAAP EPS of -$0.18 beats by $0.04, revenue of $34.41M beats by $6.29M [5/4/2023 6:03 AM]	11.33	-0.36 (-3.08%)	11.91	0.22 (1.88%)	4.07 - 13.41	4,600,357	3,310,000	260,383
Aurinia Pharma Q1 2023 Earnings Preview [5/3/2023 3:01 PM] Aurinia wins U.K. nod for lupus nephritis therapy Lupkynis [5/3/2023 8:31 AM] Aurinia Pharma GAAP EPS of -$0.18 beats by $0.04, revenue of $34.41M beats by $6.29M [5/4/2023 6:03 AM] Aurinia Pharma gains after Q1 beat and guidance raise [5/4/2023 7:48 AM]
28-02-2023	PM	6:00 AM ET (Feb 28)	AUPH	Aurinia Pharmaceuticals Inc	1,120	-0.18	-0.26	-0.25	Aurinia Pharma reports mixed Q4 earnings; reaffirms FY23 outlook [2/28/2023 6:01 AM]	9.06	0.73 (8.82%)	8.29	-0.04 (-0.48%)	4.07 - 13.41	5,182,757	2,520,000	29,612
Aurinia Pharma Q4 2022 Earnings Preview [2/27/2023 5:50 PM] Aurinia Pharma reports mixed Q4 earnings; reaffirms FY23 outlook [2/28/2023 6:01 AM] Aurinia stock rises as Q4 loss narrows, Lupkynis revenue grows; reaffirms product outlook [2/28/2023 11:15 AM]
03-11-2022	PM	6:00 AM ET (Nov 3)	AUPH	Aurinia Pharmaceuticals Inc	1,140	-0.06	-0.17	-0.39	Aurinia Pharma GAAP EPS of -$0.06 beats by $0.13, revenue of $55.78M beats by $19.38M [11/3/2022 6:05 AM]	5.18	-2.42 (-31.87%)	5.50	-2.11 (-27.73%)	5.03 - 33.97	10,578,210	3,030,000	1,479,778
Aurinia Pharma Q3 2022 Earnings Preview [11/2/2022 1:41 PM] Aurinia Pharma GAAP EPS of -$0.06 beats by $0.13, revenue of $55.78M beats by $19.38M [11/3/2022 6:05 AM] Aurinia sheds 22% as lackluster Lupkynis uptake leads to guidance cut [11/3/2022 6:57 AM]
04-08-2022	PM	6:00 AM ET (Aug 4)	AUPH	Aurinia Pharmaceuticals Inc	1,470	-0.25	-0.22	-0.37	Aurinia Pharma GAAP EPS of -$0.25 misses by $0.03, revenue of $28.2M beats by $1.16M [8/4/2022 6:01 AM]	8.52	0.02 (0.24%)	8.59	0.09 (1.06%)	7.70 - 33.97	7,456,442	3,340,000	85,861
Aurinia Pharma Q2 2022 Earnings Preview [8/3/2022 1:34 PM] Aurinia Pharma GAAP EPS of -$0.25 misses by $0.03, revenue of $28.2M beats by $1.16M [8/4/2022 6:01 AM] Aurinia narrows 2Q net loss as Lupkynis sales regain momentum [8/4/2022 7:49 AM]
10-05-2022	PM	6:00 AM ET (May 10)	AUPH	Aurinia Pharmaceuticals Inc	1,440	-0.27	-0.26	-0.40	Aurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39M [5/10/2022 6:02 AM]	11.23	2.28 (25.54%)	9.61	0.66 (7.43%)	8.86 - 33.97	4,401,304	2,910,233	103,119
Aurinia Pharma Q1 2022 Earnings Preview [5/9/2022 12:41 PM] Aurinia Pharma GAAP EPS of -$0.27 in-line, revenue of $21.63M beats by $2.39M [5/10/2022 6:02 AM] Aurinia Pharma in focus despite 1Q revenue beat as Omicron hurts Lupkynis sales [5/10/2022 7:01 AM] Aurinia Reports First Quarter 2022 Financial and Operational Results [May-10-22 06:00AM] Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Tops Revenue Estimates [May-10-22 07:15AM]
28-02-2022	PM	6:00 AM ET (Feb 28)	AUPH	Aurinia Pharmaceuticals Inc	2,070	-0.25	-0.26	-0.05	Aurinia Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $23.4M beats by $1.57M [2/28/2022 6:00 AM]	12.39	-3.85 (-23.71%)	11.68	-4.56 (-28.08%)	9.72 - 33.97	19,407,009	2,910,000	1,904,004
Aurinia Pharma GAAP EPS of -$0.25 beats by $0.02, revenue of $23.4M beats by $1.57M [2/28/2022 6:00 AM] Aurinia falls after lower-than-expected sales outlook for 2022 [2/28/2022 8:08 AM] Aurinia Reports Fourth Quarter and Full Year 2021 Financial Results and Company Updates [Feb-28-22 06:00AM] Aurinia Pharmaceuticals (AUPH) Reports Q4 Loss, Tops Revenue Estimates [Feb-28-22 07:25AM] Why Aurinia Pharmaceuticals Stock Is Crashing Today [Feb-28-22 09:43AM] Why Aurinia Pharmaceuticals Tumbled Despite Its 'Aggressive' 2022 Outlook [Feb-28-22 12:04PM] Aurinia Stock Takes a Hit, but Is It Warranted? Analyst Weighs In [Feb-28-22 04:28PM]
03-11-2021	PM	8:00 AM ET (Nov 3)	AUPH	Aurinia Pharmaceuticals Inc	4,190	-0.39	-0.31	-0.28	Aurinia Pharma EPS misses by $0.06, beats on revenue [11/3/2021 6:11 AM]	30.26	-1.74 (-5.44%)	30.20	-1.80 (-5.62%)	9.72 - 33.97	7,356,537	7,310,000	467,649
Aurinia Pharma Q3 2021 Earnings Preview [11/2/2021 11:59 AM] Aurinia Pharma EPS misses by $0.06, beats on revenue [11/3/2021 6:11 AM] Aurinia Pharma slips as uptake of lupus nephritis therapy slows [11/3/2021 8:28 AM] Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates [Nov-03-21 06:00AM] Aurinia Pharmaceuticals (AUPH) Reports Q3 Loss, Lags Revenue Estimates [Nov-03-21 07:15AM] Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals [Nov-03-21 10:15AM] Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript [Nov-03-21 03:31PM]
05-08-2021	AH	4:05 PM ET (Aug 5)	AUPH	Aurinia Pharmaceuticals Inc	1,740	-0.37	-0.35	-0.26	Aurinia Pharma EPS misses by $0.01, beats on revenue [8/5/2021 4:16 PM]	14.36	2.65 (22.63%)	13.16	1.45 (12.38%)	9.72 - 20.50	11,151,253	5,580,000	122,800
Aurinia Pharma extends gains following robust Q2 top-line growth [8/6/2021 6:08 AM] SCWorx, Aurinia Pharmaceuticals leads healthcare gainers; Dicerna Pharmaceuticals, iCAD among major losers [8/6/2021 11:02 AM] Aurinia Pharmaceuticals' Charts Are Showing Side Effects [Aug-04-21 08:40AM] Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar [Aug-05-21 06:39AM] Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights [Aug-05-21 04:05PM] Aurinia Pharmaceuticals (AUPH) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 07:55PM] Aurinia Pharmaceuticals Inc (AUPH) Q2 2021 Earnings Call Transcript [Aug-06-21 09:30AM] Why Aurinia Pharmaceuticals Stock Was Surging on Friday [Aug-06-21 01:54PM]
06-05-2021	AH	4:00 PM ET (May 6)	AUPH	Aurinia Pharmaceuticals Inc	1,610	-0.40	-0.35	-0.15	Aurinia Pharma EPS misses by $0.02, misses on revenue [5/6/2021 4:07 PM]	10.12	-2.21 (-17.95%)	10.67	-1.67 (-13.53%)	10.03 - 20.50	13,157,043	5,010,000	1,022,448
Aurinia Pharmaceuticals gains on takeover speculation [5/6/2021 8:11 AM] Aurinia Pharma EPS misses by $0.02, misses on revenue [5/6/2021 4:07 PM] Aurinia Pharma plummets as Q1 top and bottom-line trails consensus [5/7/2021 2:26 AM] Aurinia favored at Cantor despite earnings miss [5/7/2021 2:25 PM] Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights [May-06-21 04:05PM] Why Aurinia Pharmaceuticals Stock Is Crashing Today [May-06-21 05:33PM] Aurinia Pharmaceuticals, Inc. to Host Earnings Call [May-06-21 03:15PM] Aurinia Pharmaceuticals (AUPH) Reports Q1 Loss, Misses Revenue Estimates [May-06-21 07:45PM]
24-02-2021	AH	4:00 PM ET (Feb 24)	AUPH	Aurinia Pharmaceuticals Inc	2,020	-0.05	-0.31	-0.29	Aurinia Pharma EPS beats by $0.15, beats on revenue [2/24/2021 4:07 PM]	14.60	0.02 (0.14%)	15.00	0.42 (2.88%)	9.83 - 20.50	6,039,395	3,110,710	298,675
Aurinia Pharma EPS beats by $0.15, beats on revenue [2/24/2021 4:07 PM] Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights [Feb-24-21 04:02PM] Aurinia Pharmaceuticals, Inc. to Host Earnings Call [Feb-24-21 02:30PM]
10-11-2020	AH		AUPH	Aurinia Pharmaceuticals Inc	1,741	-0.28	-0.22	0.00	Aurinia Pharma EPS misses by $0.05, misses on revenue [11/10/2020 4:29 PM]	13.25	-0.32 (-2.36%)	13.77	0.20 (1.47%)	4.90 - 21.93	1,810,047	1,646,203	6,849

11-08-2020	AH	4:00 PM ET (Aug 11)	AUPH	Aurinia Pharmaceuticals Inc	1,850	-0.26	-0.23	-0.17	Aurinia Pharma EPS misses by $0.03, revenue in-line [8/11/2020 4:04 PM]	14.17	0.17 (1.21%)	13.63	-0.37 (-2.64%)	3.52 - 21.93	930,108	1,564,751	89,324

14-05-2020	AH	4:00 PM ET (May 14)	AUPH	Aurinia Pharmaceuticals Inc	2,000	-0.15	-0.20	-0.16	Aurinia Pharma EPS beats by $0.12, misses on revenue [5/14/2020 4:07 PM]	17.16	-0.24 (-1.38%)	17.13	-0.03 (-0.17%)	3.52 - 21.93	1,311,086	1,093,498	9,045